Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 6Terminated 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Tumor-Agnostic 1

Conditions

Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Anxiety Disorders 1

Interventions

Cyclophosphamide 122Cytarabine 112fludarabine 91fludarabine phosphate 80Rituximab 75Azacitidine 75venetoclax 55Methotrexate 52Filgrastim 48Whole-Body Irradiation 45Busulfan 45Tacrolimus 35Etoposide 35Mycophenolic Acid 34Lenalidomide 32Imatinib Mesylate 32Antilymphocyte Serum 32Granulocyte Colony-Stimulating Factor 31Decitabine 31Peripheral Blood Stem Cell Transplantation 29Dexamethasone 29Cyclosporine 29Vincristine 26Melphalan 26Clofarabine 25Alemtuzumab 25Mitoxantrone 24Stem Cell Transplantation 22Radiotherapy 22Dasatinib 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Behavior Therapy × Other hematologic neoplasm × Clear all
NCT05056831 2024-10-23

Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer Patients

M.D. Anderson Cancer Center

Phase NA Terminated
2 enrolled
Other hematologic neoplasm

Anxiety Disorders, Hematologic Neoplasms

NCT00150878 2013-06-20

Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission

University Hospital Carl Gustav Carus

Phase 3 Terminated
198 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡